# Jennifer K. Litton

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jennifer-k-litton/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,069 |
| Field | PARP inhibition in cancer therapy |
| h-index | 68 |
| i10-index | 183 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5014713051 |
| ORCID iD | https://orcid.org/0000-0001-8390-4985 |
| Works | 565 |

## Researcher papers

- [Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation](https://scholariq.org/papers/talazoparib-in-patients-with-advanced-breast-cancer-and-a-germline-i-brca-i/)
- [Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/genetic-familial-high-risk-assessment-breast-ovarian-and-pancreatic-version-2/)
- [Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1](https://scholariq.org/papers/metformin-promotes-antitumor-immunity-via-endoplasmic-reticulum-associated/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-and/)
- [Genetic/Familial High-Risk Assessment: Breast and Ovarian](https://scholariq.org/papers/genetic-familial-high-risk-assessment-breast-and-ovarian/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-ovarian/)

## Researcher topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.